Novartiss Jakavi ® shows positive Phase III results in - TopicsExpress



          

Novartiss Jakavi ® shows positive Phase III results in Polycythemia Vera Novartis announced that Jakavi ® (ruxolitinib) showed positive reponse in compare to present therpies for Polycythemia Vera, a rare and incurable blood cancer with increase number of erythrocytes production. In phase III trial, Jakavi ® succeed to maintain hematocrit control... read more: pharmatutor.org/pharma-news/ruxolitinibis-shows-positive-phase-III-study-in-polycythemia-vera-blood-cancer
Posted on: Fri, 14 Mar 2014 05:21:35 +0000

Trending Topics



Recently Viewed Topics




© 2015